ATE63757T1 - Expression durch verwendung von fusionsgenen fuer proteinproduktion. - Google Patents
Expression durch verwendung von fusionsgenen fuer proteinproduktion.Info
- Publication number
- ATE63757T1 ATE63757T1 AT86104066T AT86104066T ATE63757T1 AT E63757 T1 ATE63757 T1 AT E63757T1 AT 86104066 T AT86104066 T AT 86104066T AT 86104066 T AT86104066 T AT 86104066T AT E63757 T1 ATE63757 T1 AT E63757T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- superoxide dismutase
- host
- heterologous
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71720985A | 1985-03-28 | 1985-03-28 | |
| EP86104066A EP0196056B1 (de) | 1985-03-28 | 1986-03-25 | Expression durch Verwendung von Fusionsgenen für Proteinproduktion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE63757T1 true ATE63757T1 (de) | 1991-06-15 |
Family
ID=24881138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86104066T ATE63757T1 (de) | 1985-03-28 | 1986-03-25 | Expression durch verwendung von fusionsgenen fuer proteinproduktion. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0196056B1 (de) |
| JP (2) | JPH0829096B2 (de) |
| AT (1) | ATE63757T1 (de) |
| CA (1) | CA1260858A (de) |
| DE (1) | DE3679343D1 (de) |
| DK (1) | DK142186A (de) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3587759T2 (de) * | 1984-05-11 | 1994-07-07 | Chiron Corp., Emeryville, Calif. | Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion. |
| US6610520B1 (en) | 1985-11-22 | 2003-08-26 | Bio-Technology General Corp. | Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby |
| CA1339299C (en) * | 1986-09-12 | 1997-08-19 | Jacob R. Hartman | Human manganese superoxide dismutase dna; its expression; method of recovering human manganese superoxide dismutase, human manganese superoxide dismutase analogs or human manganese superoxide dismutase mutants; uses;compositions; and methods of treatment |
| ATE72581T1 (de) * | 1987-03-16 | 1992-02-15 | Chiron Corp | Superoxiddismutase-polymere. |
| US5084390A (en) * | 1987-03-16 | 1992-01-28 | Chiron Corporation | Superoxide dismutase polymers |
| DE3714866A1 (de) * | 1987-05-05 | 1988-11-24 | Hoechst Ag | Verfahren zur herstellung von fremdproteinen in streptomyceten |
| US5683894A (en) * | 1988-04-29 | 1997-11-04 | University Of California | Recombinant nerve growth factor |
| CA1324969C (en) | 1988-05-06 | 1993-12-07 | Jeffrey R. Shuster | High level expression of proteins in yeast |
| WO1990010230A1 (en) * | 1989-02-23 | 1990-09-07 | University Of Ottawa | Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine |
| JPH03151877A (ja) * | 1989-06-02 | 1991-06-28 | Chiron Corp | 骨カルシウム沈着因子 |
| US5672683A (en) * | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| KR920003787B1 (ko) * | 1990-03-05 | 1992-05-14 | 한국과학기술 연구원 | 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법 |
| JPH07108232B2 (ja) * | 1990-10-09 | 1995-11-22 | エム・ディ・リサーチ株式会社 | ペプチド又は蛋白質の製造方法 |
| IE914102A1 (en) | 1990-11-26 | 1992-06-03 | Genetics Inst | Expression of pace in host cells and methods of use thereof |
| AU2368892A (en) * | 1991-07-29 | 1993-03-02 | British Bio-Technology Limited | Igf-ii analogues |
| US5288931A (en) * | 1991-12-06 | 1994-02-22 | Genentech, Inc. | Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US5663304A (en) * | 1993-08-20 | 1997-09-02 | Genentech, Inc. | Refolding of misfolded insulin-like growth factor-I |
| US5629167A (en) | 1994-04-19 | 1997-05-13 | Biocine S.P.A. | Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| HRP940432B1 (en) * | 1994-08-05 | 2003-10-31 | Pliva Pharm & Chem Works | Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin |
| CZ290079B6 (cs) † | 1994-12-29 | 2002-05-15 | Bio-Technology General Corp. | Způsob produkce inzulinu a meziprodukt pro tento způsob |
| GB9526733D0 (en) | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
| AU4904397A (en) | 1996-10-17 | 1998-05-11 | Chiron Corporation | Protease regulator screening assay |
| US20050202499A1 (en) | 1996-10-31 | 2005-09-15 | Billing-Medel Patricia A. | Reagents and methods useful for detecting diseases of the breast |
| CA2308606A1 (en) | 1997-11-06 | 1999-05-20 | Chiron S.P.A. | Neisserial antigens |
| ATE446368T1 (de) | 1998-01-14 | 2009-11-15 | Novartis Vaccines & Diagnostic | Antigene aus neisseria meningitidis |
| GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| EP2261345A3 (de) | 1998-05-01 | 2012-01-11 | Novartis Vaccines and Diagnostics, Inc. | Antigene und Zusammensetzungen gegen Neisseria meningitidis |
| RU2245366C2 (ru) | 1999-04-30 | 2005-01-27 | Чирон С.Р.Л. | Антиген neisseria, кодирующая его нуклеиновая кислота, их использование |
| GB9911683D0 (en) | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
| GB9916529D0 (en) | 1999-07-14 | 1999-09-15 | Chiron Spa | Antigenic peptides |
| PT2275552E (pt) | 1999-10-29 | 2015-12-07 | Glaxosmithkline Biolog Sa | Péptidos antigénicos de neisseria |
| ES2588917T3 (es) | 2000-01-17 | 2016-11-07 | Glaxosmithkline Biologicals Sa | Vacuna de VME suplementada contra meningococo |
| EP1803730A1 (de) | 2000-04-12 | 2007-07-04 | Human Genome Sciences, Inc. | Albuminfusionsproteine |
| US6946134B1 (en) | 2000-04-12 | 2005-09-20 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| MXPA03003690A (es) | 2000-10-27 | 2004-05-05 | Chiron Spa | Acidos nucleicos y proteinas de los grupos a y b de estreptococos. |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| US7507413B2 (en) | 2001-04-12 | 2009-03-24 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7629309B2 (en) | 2002-05-29 | 2009-12-08 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| US7560424B2 (en) | 2001-04-30 | 2009-07-14 | Zystor Therapeutics, Inc. | Targeted therapeutic proteins |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| US20030072761A1 (en) | 2001-10-16 | 2003-04-17 | Lebowitz Jonathan | Methods and compositions for targeting proteins across the blood brain barrier |
| ES2312649T3 (es) | 2001-12-12 | 2009-03-01 | Novartis Vaccines And Diagnostics S.R.L. | Inmunizacion frente a chlamydia trachomatis. |
| EP1997829A1 (de) | 2001-12-21 | 2008-12-03 | Human Genome Sciences, Inc. | Albumin Fusionsproteine |
| WO2004046177A2 (en) | 2002-11-15 | 2004-06-03 | Chiron Srl | Unexpected surface proteins in neisseria meningitidis |
| CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| ES2306981T3 (es) | 2003-01-31 | 2008-11-16 | N.V. Organon | Metodo para aislamiento de proteinas en condiciones anoxicas. |
| GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
| CN1922313B (zh) | 2004-02-10 | 2011-10-26 | 生物马林医药公司 | 酸性α-糖苷酶及其片段 |
| WO2008020335A2 (en) | 2006-06-09 | 2008-02-21 | Novartis Ag | Immunogenic compositions for streptococcus agalactiae |
| US8138318B2 (en) | 2007-09-13 | 2012-03-20 | Abbott Laboratories | Hepatitis B pre-S2 nucleic acid |
| BRPI0912225A2 (pt) | 2008-05-07 | 2018-03-20 | Zystor Therapeutics, Inc. | peptídeos de direcionamento lisossomais e usos dos mesmos |
| EP2475376B1 (de) | 2009-06-17 | 2016-03-30 | BioMarin Pharmaceutical Inc. | Formulierungen für lysosomale enzyme |
| US20150191506A1 (en) * | 2012-06-29 | 2015-07-09 | Asahi Kasei Medical Co., Ltd. | Adsorbent consisting of carrier which bound with polypeptide comprising b-domain mutant derived from protein a |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
| SE8300693L (sv) * | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
| EP0561137B1 (de) * | 1983-04-25 | 2002-07-03 | Chiron Corporation | Hybrid-DNS-Synthesis von reifen insulinähnlichen Wachstumsfaktoren |
| GB8314362D0 (en) * | 1983-05-24 | 1983-06-29 | Celltech Ltd | Polypeptide and protein products |
| DE3410437A1 (de) * | 1984-03-22 | 1985-09-26 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von proteinen |
-
1986
- 1986-03-25 EP EP86104066A patent/EP0196056B1/de not_active Expired - Lifetime
- 1986-03-25 DE DE8686104066T patent/DE3679343D1/de not_active Expired - Lifetime
- 1986-03-25 AT AT86104066T patent/ATE63757T1/de not_active IP Right Cessation
- 1986-03-25 CA CA000504984A patent/CA1260858A/en not_active Expired
- 1986-03-26 DK DK142186A patent/DK142186A/da not_active Application Discontinuation
- 1986-03-28 JP JP61070648A patent/JPH0829096B2/ja not_active Expired - Lifetime
-
1993
- 1993-03-01 JP JP5040008A patent/JP2545686B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1260858A (en) | 1989-09-26 |
| JPH0829096B2 (ja) | 1996-03-27 |
| JP2545686B2 (ja) | 1996-10-23 |
| DK142186A (da) | 1986-09-29 |
| EP0196056A2 (de) | 1986-10-01 |
| JPS61268193A (ja) | 1986-11-27 |
| JPH0614793A (ja) | 1994-01-25 |
| EP0196056B1 (de) | 1991-05-22 |
| EP0196056A3 (en) | 1987-12-23 |
| DE3679343D1 (de) | 1991-06-27 |
| DK142186D0 (da) | 1986-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE63757T1 (de) | Expression durch verwendung von fusionsgenen fuer proteinproduktion. | |
| AU585857B2 (en) | Recombinant fusion proteins | |
| CA2541651A1 (en) | Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy | |
| CA2168429A1 (en) | Expression of fusion polypeptides transported out of cytoplasm without leader sequences | |
| EP1027437B8 (de) | Verwendung des wnt-1 induzierten sekretierten polypeptids wisp-1 | |
| ES8602136A1 (es) | Procedimiento para producir hormona de crecimiento de humano | |
| AU3676595A (en) | Expression and export technology of proteins as immunofusins | |
| DE68922917D1 (de) | KEX2-Endoprotease und Verfahren zu ihrer Herstellung. | |
| HUT43629A (en) | Process for producing fusion proteins | |
| KR890014738A (ko) | 단백질 합성의 cks 방법 | |
| EP0206783A3 (de) | Expression und Sekretion von Polypeptiden aus Saccharomyces cerevisiae | |
| GR3026176T3 (en) | Protein complexes having factor viii:c activity and production thereof | |
| ATE364703T1 (de) | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen | |
| WO2001051635A3 (en) | Novel stra6 polypeptides | |
| DE69426289D1 (de) | Signalsequenzen für die Secretion heterologer Proteine von Hefe | |
| AU7873798A (en) | N-terminally extended proteins expressed in yeast | |
| DE3686365D1 (de) | Herstellungsverfahren fuer humanes atriales natriuretisches polypeptid. | |
| WO1998022587A3 (en) | Pituitary-tumor-transforming-genes, and related products | |
| KR870007280A (ko) | 바실러스에서의 사람 혈청 알부민의 제조방법 | |
| IL92178A (en) | Process for the preparation of an insulin precursor in streptomycetes | |
| EP0315950A3 (de) | Verfahren zur Züchtung von Zellen, welche rekombinantes Protein exprimieren | |
| SE8802939D0 (sv) | A method for the production and isolation of a fusion protein in eukaryotic cells | |
| EP0750040A3 (de) | Varianten des Makrophagen-stimulierendes-Proteins und Verfahren zur ihrer Herstellung | |
| RU92004585A (ru) | Промотор, днк-последовательность, вектор, клетки, способ экспрессии днк | |
| JPS6410986A (en) | Production of lysozyme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |